Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19
cannabis investing Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment
cannabis investing Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category
cannabis investing Lexaria Biosciences and Cannadips CBD reached definitive Technology Licensing agreement for CBD Oral Pouch & Dip Category
Revolve Receives Approval from the Alberta Utilities Commission for the 15.7 MW Bright Meadows Solar Project
Silver47 Announces Closing of $23 Million Brokered LIFE Financing, Including Full Exercise of the Over-Allotment Option
FPX Nickel Announces Funding Contribution from Natural Resources Canada to Advance the Baptiste Nickel Project